Repro Med Systems Inc (REPR)

[blue_skies]

@MWM - I see more upside.

Uplisting to a major exchange coming. This will bring additional visibility.

Two of three lawsuits settled favorably. Less legal expenses going forward. Strong incentive for EMED to settle.

Manufacturing efficiencies kicking in.

Look for product refinement and new product introductions as a result of a focused R&D program.

Sales of pumps and needle sets supporting Grifols’ SubQ Xembify will begin in fourth quarter and ramp up through next year. Possible bump in Q4 sales for Grifols’ Xembify subQ product launch??